- Report
- December 2023
- 153 Pages
Global
From €2166EUR$2,475USD£1,883GBP
€4332EUR$4,950USD£3,766GBP
- Report
- April 2024
- 88 Pages
France
From €3063EUR$3,500USD£2,663GBP
- Report
- November 2024
- 180 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- February 2024
- 179 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- December 2024
- 200 Pages
Global
From €3282EUR$3,750USD£2,853GBP
- Report
- May 2024
- 200 Pages
Global
From €3632EUR$4,150USD£3,157GBP
- Report
- February 2024
- 110 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- February 2024
- 114 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- February 2024
- 110 Pages
Global
From €4157EUR$4,750USD£3,614GBP
- Report
- April 2024
- 114 Pages
Global
From €2593EUR$2,963USD£2,254GBP
€3457EUR$3,950USD£3,005GBP
- Report
- July 2023
- 119 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- August 2024
- 200 Pages
Global
From €4331EUR$4,949USD£3,765GBP
- Report
- August 2024
- 111 Pages
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2024
- 117 Pages
Africa, Middle East
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2024
- 130 Pages
Asia Pacific
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2024
- 124 Pages
Europe
From €3019EUR$3,450USD£2,625GBP
- Report
- August 2024
- 127 Pages
North America
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2024
- 74 Pages
From €3019EUR$3,450USD£2,625GBP
- Report
- June 2024
- 80 Pages
Middle East, Africa
From €3019EUR$3,450USD£2,625GBP
- Report
- November 2023
- 176 Pages
Global
From €3895EUR$4,450USD£3,385GBP

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more